Natural killer cells: potential biomarkers and therapeutic target in autoimmune diseases?
E Gianchecchi, DV Delfino, A Fierabracci - Frontiers in immunology, 2021 - frontiersin.org
Autoimmune diseases recognize a multifactorial pathogenesis, although the exact
mechanism responsible for their onset remains to be fully elucidated. Over the past few …
mechanism responsible for their onset remains to be fully elucidated. Over the past few …
The role of natural killer cells in liver inflammation
The liver is an important immunological site that can promote immune tolerance or
activation. Natural killer (NK) cells are a major immune subset within the liver, and therefore …
activation. Natural killer (NK) cells are a major immune subset within the liver, and therefore …
The nuclear export protein XPO1 provides a peptide ligand for natural killer cells
MD Blunt, H Fisher, RB Schittenhelm, B Mbiribindi… - Science …, 2024 - science.org
XPO1 (Exportin-1/CRM1) is a nuclear export protein that is frequently overexpressed in
cancer and functions as a driver of oncogenesis. Currently small molecules that target XPO1 …
cancer and functions as a driver of oncogenesis. Currently small molecules that target XPO1 …
[PDF][PDF] Immunologic responses and the pathophysiology of primary biliary cholangitis
R Chen, R Tang, X Ma, ME Gershwin - Clinics in Liver Disease, 2022 - Elsevier
Primary biliary cholangitis (PBC) is an autoimmune liver disease with striking female
predisposition, and selective destruction of intrahepatic small bile ducts leading to non …
predisposition, and selective destruction of intrahepatic small bile ducts leading to non …
[HTML][HTML] Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis via regulation of TGF-β/Smad signaling pathway
GL Zou, S Zuo, S Lu, RH Hu, YY Lu… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND Liver fibrosis is a refractory disease whose persistence can eventually
induce cirrhosis or even liver cancer. Early liver fibrosis is reversible by intervention. As a …
induce cirrhosis or even liver cancer. Early liver fibrosis is reversible by intervention. As a …
The genetic architecture of primary biliary cholangitis
Primary biliary cholangitis (PBC) is a rare autoimmune disease of the liver affecting the small
bile ducts. From a genetic point of view, PBC is a complex trait and several genetic and …
bile ducts. From a genetic point of view, PBC is a complex trait and several genetic and …
Invariant natural killer T cells in autoimmune cholangiopathies: Mechanistic insights and therapeutic implications
Invariant natural killer T cells (iNKT cells) constitute a specialized subset of lymphocytes that
bridges innate and adaptive immunity through a combination of traits characteristic of both …
bridges innate and adaptive immunity through a combination of traits characteristic of both …
Disturbed natural killer cell homeostasis in the salivary gland enhances autoimmune pathology via IFN-γ in a mouse model of primary Sjögren's syndrome
M Sato, R Arakaki, H Tawara, R Nagao… - Frontiers in …, 2022 - frontiersin.org
Objective Innate lymphoid cells (ILCs), including natural killer (NK) cells, ILC1, ILC2,
lymphoid tissue-inducer (LTi) cells, and ILC3 cell, play a key role in various immune …
lymphoid tissue-inducer (LTi) cells, and ILC3 cell, play a key role in various immune …
Peroxisome proliferator-activated receptors regulate hepatic immunity and assist in the treatment of primary biliary cholangitis
C Wang, Y Shi, X Wang, H Ma, Q Liu, Y Gao… - Frontiers in …, 2022 - frontiersin.org
Fibrates, which are agonists of peroxisome proliferator-activated receptor alpha, have
received increasing attention in the treatment of primary biliary cholangitis. Reduced …
received increasing attention in the treatment of primary biliary cholangitis. Reduced …
An insight into the mechanism and molecular basis of dysfunctional immune response involved in cholestasis
M Zou, A Wang, J Wei, H Cai, Z Yu, L Zhang… - International …, 2021 - Elsevier
Cholestasis is one of the most common clinical symptom of liver diseases. If patients do not
receive effective treatment, cholestasis can evolve into liver fibrosis, cirrhosis and ultimately …
receive effective treatment, cholestasis can evolve into liver fibrosis, cirrhosis and ultimately …